Keckley Report September 9, 2019
Paul Keckley

Congress returns to DC this week and the agenda for health industry watchers is full: here’s my top 3:

  1. Reactions to the Oklahoma opioid verdict against J&J: On August 26, Cleveland County District Court Judge Thad Balkman ruled that Johnson and Johnson and its Janssen Pharmaceuticals subsidiary played a role in the opioid crisis and ordered the company to pay a $572 million penalty. Similar lawsuits are pending in CA, NY and MD and others might follow. The court’s final judgement is expected this week after which the defendants have 5 days to comment. J&J is likely to appeal based on its assertion that the company has operated in compliance with federal and state laws and the Judge’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Insurance, Pharma, Pricing / Spending, Provider, Regulations
Biden cracks down on junk health plans
White House issues federal agency policy on AI use, oversight
Administration finalizes rule limiting short-term, limited-duration insurance
White House Wants Chief AI Officers to Keep Federal AI Use Responsible
GOP plans for Medicaid cuts could face backlash

Share This Article